title: Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.
abstract: Prostacyclin analogues such as epoprostenol (Flolan®) are commonly used in the treatment of pulmonary arterial hypertension (PAH). However, their complex administration and significant cost may limit the access that patients with PAH have to palliative and hospice care. We herein report our experience using epoprostenol in a dedicated palliative care unit and present our inpatient protocol for the drug's administration.
authors.affiliation: Department of Internal Medicine, Division of General Medicine, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
authors.forename: Colin P
authors.initials: CP
authors.lastname: Wozencraft
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: Coyne
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Grinnan
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Morel
authors.forename: Katie M
authors.initials: KM
authors.lastname: Muzevich
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Smith
mesh_terms: D011464:Epoprostenol / Q000627:therapeutic use*; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008875:Middle Aged; D010166:Palliative Care
chemical_list: D011464:Epoprostenol